Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Teva Pharmaceutical Industries - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
TEVA
New York
2834
https://www.tevapharm.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Teva Pharmaceutical Industries
Bausch (BHC) Soars 6.4%: Is Further Upside Left in the Stock?
- Mar 28th, 2024 9:23 am
Institutional investors have a lot riding on Teva Pharmaceutical Industries Limited (NYSE:TEVA) with 67% ownership
- Mar 26th, 2024 10:30 am
Will Corcept (CORT) Bank on Korlym in 2024 Amid Stiff Rivalry?
- Mar 25th, 2024 2:20 pm
25 Countries with the Lowest Fertility Rates
- Mar 24th, 2024 11:30 pm
Q4 2023 Alvotech SA Earnings Call
- Mar 22nd, 2024 3:10 am
GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US
- Mar 21st, 2024 4:29 pm
AstraZeneca (AZN) Follows Boehringer, to Cap Inhaler Cost in US
- Mar 19th, 2024 5:46 pm
Now That Two Inhaler Makers Are Capping Patient Costs, Will More Follow?
- Mar 18th, 2024 7:06 pm
EVP, CFO Eliyahu Kalif Sells 77,550 Shares of Teva Pharmaceutical Industries Ltd (TEVA)
- Mar 8th, 2024 10:00 am
Teva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO® in China
- Feb 26th, 2024 12:00 pm
Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®
- Feb 24th, 2024 1:15 am
Teva Presents New Data Supporting Safety, Tolerability and Target Engagement of Anti-TL1A (TEV-‘574) Antibody at the 2024 ECCO Annual Meeting
- Feb 20th, 2024 1:30 pm
UPDATE 2-Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO
- Feb 20th, 2024 9:43 am
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Call Transcript
- Feb 16th, 2024 2:04 pm
Q4 2023 Corcept Therapeutics Inc Earnings Call
- Feb 16th, 2024 1:57 pm
Decoding Teva Pharmaceutical Industries Ltd (TEVA): A Strategic SWOT Insight
- Feb 13th, 2024 5:08 am
Teva Pharmaceutical upgraded at Piper Sandler
- Feb 12th, 2024 3:18 pm
David Abrams Adjusts Portfolio, Meta Platforms Sees Notable Reduction
- Feb 9th, 2024 10:02 pm
Chief Accounting Officer Amir Weiss Sells 31,766 Shares of Teva Pharmaceutical Industries Ltd
- Feb 5th, 2024 2:02 pm
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Just Reported And Analysts Have Been Lifting Their Price Targets
- Feb 2nd, 2024 11:04 am
Scroll